Polycystic Ovary Syndrome: Comprehensive Management in Primary Care

    September 2002 in “ Comprehensive Therapy ”
    George P Samraj, Louis Kuritzky
    Image of study
    TLDR Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.
    The document from 2002 provides a comprehensive overview of Polycystic Ovary Syndrome (PCOS), a common endocrino-metabolic disorder affecting 3.5%-11% of premenopausal women in the US. It is characterized by symptoms such as hyperandrogenism, insulin resistance, and chronic anovulation, leading to a variety of health issues including menstrual abnormalities, infertility, and increased risks of cardiovascular disease, Type 2 diabetes, and endometrial cancer. The document emphasizes the importance of primary care clinicians in recognizing and managing PCOS due to its diverse presentations and significant health implications. Diagnosis is primarily clinical, supported by laboratory evaluations and sometimes imaging. Management strategies include lifestyle changes, pharmacotherapy with oral contraceptives and anti-androgens, and insulin sensitizers like metformin and thiazolidinediones, which have shown favorable impacts on PCOS symptoms. The document also notes the potential of investigational treatments and the importance of addressing psychosocial issues associated with PCOS.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 107 results

      community Proposed new pathogenesis model for androgenetic alopecia (AGA)

      in Research/Science  8 upvotes 1 year ago
      The conversation discusses a new model for understanding androgenetic alopecia (AGA), linking it to dietary and lifestyle factors similar to PCOS, and highlighting the role of DHT, vascular damage, and inflammation. Treatments mentioned include Minoxidil, finasteride, and RU58841.

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 1 year ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  38 upvotes 6 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community Spironolactine Update: 2 months (34, Female)

      in Female  22 upvotes 8 years ago
      A female user's experience using Spironolactone to treat Female Pattern Hair Loss (FPHL) and Androgenic Alopecia, as well as discussing the effectiveness of the drug at different dosages.

    Similar Research

    5 / 1000+ results